Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapy
Pol Arch Intern Med. 2017 Jun 30;127(6):386-387.
doi: 10.20452/pamw.4057.
Epub 2017 Jun 30.